Challenge
INTCO is a Chinese company and the world market leader in medical disposable gloves. The company plays a central role in securing reliable, high-quality medical supplies for hospitals, healthcare providers, and patients worldwide.
The European Commission considered applying the International Procurement Instrument (IPI), which could restrict third-country suppliers’ access to EU public tenders. For INTCO, this risked exclusion from medical procurements across the Union—threatening supply continuity, competitive pricing, and Europe’s preparedness for future health emergencies, including the next pandemic.
Strategy
Alber & Geiger engaged the European Commission and the European Parliament, and coordinated with key Member States to prevent discriminatory treatment under the IPI. We made the cross-institutional case that open competition in medical tenders strengthens supply resilience, affordability, and strategic autonomy, safeguarding the Union’s readiness for the next pandemic.
Results
INTCO preserved full access to EU procurement and maintained its ability to compete in medical tenders across Europe. European hospitals retained reliable and affordable access to essential disposable gloves and supplies—reinforcing the Union’s health security and preparedness for future crises.